Key result
Bladder signet ring cell carcinoma causes fatal pulmonary tumor thrombotic microangiopathy shortly after TURBT.
Why the study?
Pulmonary tumor thrombotic microangiopathy is a rare and fatal complication of malignancy, with few reported cases involving bladder cancer.
Case Report (n=1)
No
Pulmonary tumor thrombotic microangiopathy can arise from primary bladder signet ring cell adenocarcinoma and should be suspected in cancer patients presenting with progressive dyspnea, echocardiographic right heart abnormalities, and recurrent perioperative desaturation.
Alerts to possible fatal pulmonary tumor thrombotic microangiopathy after TURBT in signet ring bladder adenocarcinoma with pulmonary hypertension; extends tumor sources and leaves risk mitigation open.
Introduction Pulmonary tumor thrombotic microangiopathy is a rare, fatal complication of malignancy, with few reports involving bladder cancer. Case Presentation An 81‐year‐old man with chronic obstructive pulmonary disease presented with hematuria and progressive exertional dyspnea. Imaging showed an invasive bladder tumor with lymph node metastases. Echocardiography suggested pulmonary hypertension, although invasive confirmation was unavailable. Recurrent perioperative oxygen desaturation preceded fatal deterioration 2 days after transurethral resection. Autopsy revealed primary bladder adenocarcinoma, signet ring cell subtype, and microscopic pulmonary tumor emboli with fibrin thrombi, fibrous intimal thickening, and recanalization. These findings supported pulmonary tumor thrombotic microangiopathy. Distinct gastrointestinal tumors and matching bladder and metastatic morphology supported a bladder origin. Conclusion Pulmonary tumor thrombotic microangiopathy should be considered in patients with bladder tumors and progressive dyspnea. Recurrent desaturation and right heart abnormalities warrant reassessment despite preserved oxygen saturation. Autopsy vascular findings were essential to distinguish this condition from simple pulmonary tumor embolism.
No takes yet. Share an insight, caveat, or question.
Kodani et al. (2026) conducted a case report in Pulmonary tumor thrombotic microangiopathy originating from primary bladder adenocarcinoma (n=1). Diagnostic transurethral resection of the bladder tumor (TURBT) was evaluated on Autopsy-confirmed diagnosis of pulmonary tumor thrombotic microangiopathy and clinical course. Primary bladder signet ring cell adenocarcinoma caused fatal pulmonary tumor thrombotic microangiopathy with pre-existing pulmonary hypertension (TRV 3.1 m/s) and death 2 days after TURBT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: